{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:42:33Z","timestamp":1785156153868,"version":"3.55.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharmthera.2025.108796","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:10:54Z","timestamp":1736813454000},"page":"108796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["G protein-coupled purinergic P2Y receptors in infectious diseases"],"prefix":"10.1016","volume":"267","author":[{"given":"Let\u00edcia de Almeida","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Santos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson","family":"Coutinho-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo Baggio","family":"Savio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2218\/gtopdb\/F52\/2019.4","article-title":"P2Y receptors (version 2019.4) in the IUPHAR\/BPS guide to pharmacology database","volume":"2019","author":"Abbracchio","year":"2019","journal-title":"IUPHAR\/BPS Guide to Pharmacology CITE"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21091114","article-title":"Identification of a new morpholine scaffold as a P2Y12 receptor antagonist","volume":"21","author":"Ahn","year":"2016","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108796_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells12141844","article-title":"S1P Lyase deficiency in the brain promotes astrogliosis and NLRP3 inflammasome activation via purinergic signaling","volume":"12","author":"Alam","year":"2023","journal-title":"Cells"},{"issue":"July","key":"10.1016\/j.pharmthera.2025.108796_bb0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbi.2020.07.026","article-title":"Purinergic signaling in infectious diseases of the central nervous system","volume":"89","author":"Alves","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"issue":"April","key":"10.1016\/j.pharmthera.2025.108796_bb0025","first-page":"1","article-title":"SARS-CoV-2 spike protein alters microglial purinergic signaling","volume":"14","author":"Alves","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"23","key":"10.1016\/j.pharmthera.2025.108796_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2022113279","article-title":"Systematic P2Y receptor survey identifies P2Y11 as modulator of immune responses and virus replication in macrophages","volume":"42","author":"Andersen","year":"2023","journal-title":"The EMBO Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0035","doi-asserted-by":"crossref","first-page":"G471","DOI":"10.1152\/ajpgi.00090.2023","article-title":"P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality","volume":"325","author":"Arunachalam","year":"2023","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1006\/bbrc.1996.0139","article-title":"Cloning and chromosomal localization of the human P2Y1 purinoceptor","volume":"218","author":"Ayyanathan","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejmech.2013.04.007","article-title":"Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor","volume":"65","author":"Bach","year":"2013","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-10-358","article-title":"Roles and functions of HIV-1 tat protein in the CNS: An overview","volume":"10","author":"Bagashev","year":"2013","journal-title":"Virology Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bib846","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40261-014-0236-8","article-title":"A new reversible and potent P2Y12 receptor antagonist (ACT-246475): tolerability, pharmacokinetics, and pharmacodynamics in a first-in-man trial","volume":"34","author":"Baldoni","year":"2014","journal-title":"Clin Drug Investig"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bb0055","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/jm9003297","article-title":"High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors","volume":"52","author":"Baqi","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.113.085654","article-title":"A selective high-affinity antagonist of the P2Y14 receptor inhibits udp-glucose-stimulated chemotaxis of human neutrophilss","volume":"84","author":"Barrett","year":"2013","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: A randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14428","article-title":"Effect of P2Y12 inhibitors on organ support-free survival in critically ill patients hospitalized for COVID-19: A randomized clinical trial","volume":"6","author":"Berger","year":"2023","journal-title":"JAMA Network Open"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108796_bb0075","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1021\/jm060485n","article-title":"Structure-activity relationships of uridine 5\u2032-diphosphate analogues at the human P2Y6 receptor","volume":"49","author":"Besada","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020374","article-title":"Inhibitory effect of flavonolignans on the P2Y12 pathway in blood platelets","volume":"23","author":"Bijak","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjp.0701880","article-title":"Molecular cloning and characterization of rat P2Y4 nucleotide receptor","volume":"124","author":"Bogdanov","year":"1998","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0701837","article-title":"Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2\u2032-deoxyadenosine 3\u2032,5\u2032-bisphosphate","volume":"124","author":"Boyer","year":"1998","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108796_bb0095","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/ATVBAHA.123.319099","article-title":"Cell surface platelet tissue factor expression: Regulation by P2Y12and link to residual platelet reactivity","volume":"43","author":"Brambilla","year":"2023","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0100","first-page":"648","article-title":"Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5\u2032-nucleotide receptor in human airway epithelial cells","volume":"40","author":"Brown","year":"1991","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/092986706775476052","article-title":"P2 receptors activated by uracil nucleotides - an update","volume":"13","author":"Brunschweiger","year":"2006","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Do some nerve cells release more than one transmitter?","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0120","series-title":"Cell membrane receptors for drugs and hormones: A multidisciplinary approach","first-page":"107","author":"Burnstock","year":"1978"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0125","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02008.x","article-title":"Discovery of purinergic signalling, the initial resistance and current explosion of interest","volume":"167","author":"Burnstock","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1476-5381.1970.tb10646.x","article-title":"Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut","volume":"40","author":"Burnstock","year":"1970","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"General Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/hq0302.105360","article-title":"Purinergic signaling and vascular cell proliferation and death","volume":"22","author":"Burnstock","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108796_bb0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/1573406415666190208124534","article-title":"Structure activity relationship of 4-Amino-2-thiopyrimidine derivatives as platelet aggregation inhibitors","volume":"15","author":"Cacciari","year":"2019","journal-title":"Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/mol.109.058578","article-title":"Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor","volume":"76","author":"Carter","year":"2009","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0155","first-page":"15","article-title":"Purinergic signaling in the battlefield of viral infections","volume":"0123456789","author":"Carvalho-Barbosa","year":"2023","journal-title":"Purinergic Signalling"},{"issue":"15","key":"10.1016\/j.pharmthera.2025.108796_bb0160","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.275.15.10767","article-title":"A G protein-coupled receptor for UDP-glucose","volume":"275","author":"Chambers","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"44","key":"10.1016\/j.pharmthera.2025.108796_bb0165","doi-asserted-by":"crossref","first-page":"26152","DOI":"10.1074\/jbc.270.44.26152","article-title":"Molecular cloning and functional analysis of a novel P2 nucleotide receptor","volume":"270","author":"Chang","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"6519","key":"10.1016\/j.pharmthera.2025.108796_bb0170","first-page":"1","volume":"370","author":"Chang-graham","year":"2021","journal-title":"HHS Public Access"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108796_bb0175","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.4049\/jimmunol.1301058","article-title":"Leukotriene B4 modulates P2X7 receptor\u2013mediated Leishmania amazonensis elimination in murine macrophages","volume":"192","author":"Chaves","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"5806","key":"10.1016\/j.pharmthera.2025.108796_bb0180","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1132559","article-title":"ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0185","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1124\/jpet.104.068650","article-title":"Induction of novel agonist selectivity for the ADP-activated P2Y 1 receptor versus the ADP-activated P2Y12 and P2Y 13 receptors by conformational constraint of an ADP analog","volume":"311","author":"Chhatriwala","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0190","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2013-04-496216","article-title":"TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses","volume":"122","author":"Cohen","year":"2013","journal-title":"Blood"},{"issue":"44","key":"10.1016\/j.pharmthera.2025.108796_bb0195","doi-asserted-by":"crossref","first-page":"41479","DOI":"10.1074\/jbc.M105912200","article-title":"Identification of a novel human ADP receptor coupled to Gi","volume":"276","author":"Communi","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"51","key":"10.1016\/j.pharmthera.2025.108796_bb0200","doi-asserted-by":"crossref","first-page":"31969","DOI":"10.1074\/jbc.272.51.31969","article-title":"Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase","volume":"272","author":"Communi","year":"1997","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/bbrc.1996.0739","article-title":"Cloning, functional expression and tissue distribution of the human P2Y6 receptor","volume":"222","author":"Communi","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"52","key":"10.1016\/j.pharmthera.2025.108796_bb0210","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.270.52.30849","article-title":"Cloning and functional expression of a human uridine nucleotide receptor","volume":"270","author":"Communi","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108796_bb0215","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1021\/acs.jmedchem.8b00139","article-title":"Synthesis and evaluation of the first fluorescent antagonists of the human P2Y 2 receptor based on AR-C118925","volume":"61","author":"Conroy","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/tropicalmed7040054","article-title":"Immune responses in Leishmaniases: An overview","volume":"7","author":"Costa-Da-silva","year":"2022","journal-title":"Tropical Medicine and Infectious Disease"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108796_bb0225","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.micinf.2012.05.009","article-title":"Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites","volume":"14","author":"Coutinho-Silva","year":"2012","journal-title":"Microbes and Infection"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.99431","article-title":"Macrophage P2X4 receptors augment bacterial killing and protect against sepsis","volume":"3","author":"Cs\u00f3ka","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0235","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1074\/jbc.273.4.2024","article-title":"Molecular basis for ADP-induced platelet activation: I. Evidence for three distinct ADP receptors on human platelets","volume":"273","author":"Daniel","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/jm901432g","article-title":"Human P2Y14 receptor agonists: Truncation of the hexose moiety of uridine-5\u2032-diphosphoglucose and its replacement with alkyl and aryl groups","volume":"53","author":"Das","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19041222","article-title":"Mechanisms of ATP release by inflammatory cells","volume":"19","author":"Dosch","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.42670","article-title":"Connexin-43-dependent ATP release mediates macrophage activation during sepsis","volume":"8","author":"Dosch","year":"2019","journal-title":"ELife"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart1","volume":"68","author":"Drury","year":"1929","journal-title":"The Journal of Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0265","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjp.0706887","article-title":"Opposite diastereoselective activation of P2Y 1 and P2Y 11 nucleotide receptors by adenosine 5\u2032-O-(\u03b1- boranotriphosphate) analogues","volume":"149","author":"Ecke","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"7261","key":"10.1016\/j.pharmthera.2025.108796_bb0270","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.pharmthera.2025.108796_bb0275","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1021\/jm060848j","article-title":"Synthesis and structure\u2212activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y 2, P2Y 4, and P2Y 6 receptors","volume":"49","author":"El-Tayeb","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0280","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00424-006-0069-2","article-title":"P2 receptors: Intracellular signaling","volume":"452","author":"Erb","year":"2006","journal-title":"Pfl\u00fcgers Archiv \/ European Journal of Physiology"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108796_bb0285","doi-asserted-by":"crossref","first-page":"10449","DOI":"10.1073\/pnas.90.22.10449","article-title":"Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor","volume":"90","author":"Erb","year":"1993","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0290","first-page":"789","article-title":"Coupling of P2Y receptors to G proteins and other signaling pathways","volume":"1","author":"Erb","year":"2012","journal-title":"Wiley Interdisciplinary Reviews: Membrane Transport and Signaling"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0295","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-018-1885-0","article-title":"Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms","volume":"136","author":"Fekete","year":"2018","journal-title":"Acta Neuropathologica"},{"issue":"June","key":"10.1016\/j.pharmthera.2025.108796_bb0300","first-page":"1","article-title":"The potential of purinergic signaling to thwart viruses including SARS-CoV-2","volume":"13","author":"Ferrari","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(25)08672-9","article-title":"Expression of a cloned P2Y purinergic receptor that couples to phospholipase C","volume":"46","author":"Filtz","year":"1994","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bib843","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI12242","article-title":"Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs","volume":"107","author":"Foster","year":"2001","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - An update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bib849","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.109.150730","article-title":"Gi-dependent cell signaling responses of the human P2Y 14 receptor in model cell systems","volume":"330","author":"Fricks","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"March","key":"10.1016\/j.pharmthera.2025.108796_bb0320","article-title":"UDP\/P2Y6 contributes to enhancing LPS-induced acute lung injury by regulating neutrophil migration","volume":"376","author":"Fu","year":"2022","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2004.02.039","article-title":"2,2\u2032-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding","volume":"68","author":"Gao","year":"2004","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0330","doi-asserted-by":"crossref","first-page":"L890","DOI":"10.1152\/ajplung.00428.2004","article-title":"Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa","volume":"289","author":"Geary","year":"2005","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0335","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/jm901450d","article-title":"5-OMe-UDP is a potent and selective P2Y6-receptor agonist","volume":"53","author":"Ginsburg-Shmuel","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"issue":"February","key":"10.1016\/j.pharmthera.2025.108796_bb0340","first-page":"1","article-title":"Ectonucleotidases in acute and chronic inflammation","volume":"11","author":"Giuliani","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108796_bb0345","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1073\/pnas.1503474112","article-title":"Infection by toxoplasma gondii, a severe parasite in neonates and AIDS patients, causes impaired anion secretion in airway epithelia","volume":"112","author":"Guo","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bb0350","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0355","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.1102482","article-title":"Purinergic receptors are required for HIV-1 infection of primary human macrophages","volume":"188","author":"Hazleton","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V92.1.152.413k27_152_159","article-title":"The P2Y1 receptor is necessary for adenosine 5\u2032-diphosphate-induced platelet aggregation","volume":"92","author":"Hechler","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0365","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1006\/bbrc.1995.2018","article-title":"Cloning and characterization of a bovine P2Y receptor \u222e","volume":"212","author":"Henderson","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bib847","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2003-40669","article-title":"P2Y 12, A New Platelet ADP Receptor, Target of Clopidogrel","volume":"03","author":"Herbert","year":"2003","journal-title":"Seminars in Vascular Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bib842","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/jm801442p","article-title":"Key determinants of nucleotide-activated G protein-coupled P2Y2 receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling","volume":"52","author":"Hillmann","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0370","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/jth.12719","article-title":"Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12-receptor","volume":"12","author":"Hoffmann","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0375","first-page":"439","article-title":"Neurite outgrowth of striatal neurons in vitro: Involvement of purines in the growth-promoting effect of myenteric plexus explants","volume":"14","author":"H\u00f6pker","year":"1996","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0380","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/138620708784911474","article-title":"Development of selective high affinity antagonists, agonists, and Radioligands for the P2Y1 receptor","volume":"11","author":"Houston","year":"2008","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0385","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706453","article-title":"[32P]2-iodo-N 6-methyl-(N)-methanocarba-2\u2032- deoxyadenosine-3\u2032,5\u2032-bisphosphate ([ 32P]MRS2500), a novel radioligand for quantification of native P2Y 1 receptors","volume":"147","author":"Houston","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"7500","key":"10.1016\/j.pharmthera.2025.108796_bb0390","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm981072s","article-title":"Antagonists of the platelet P(2t) receptor: A novel approach to antithrombotic therapy","volume":"42","author":"Ingall","year":"1999","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SHK.0b013e318160dad4","article-title":"A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis","volume":"30","author":"Inoue","year":"2008","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0405","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/jm060903o","article-title":"Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2\u2032-amino-2\u2032-deoxy-2-thiouridine 5\u2032-triphosphate","volume":"50","author":"Ivanov","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11302-018-9614-7","article-title":"A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist","volume":"14","author":"Jacob","year":"2018","journal-title":"Purinergic Signalling"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0415","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11302-008-9106-2","article-title":"Development of selective agonists and antagonists of P2Y receptors","volume":"5","author":"Jacobson","year":"2009","journal-title":"Purinergic Signalling"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.114.095711","article-title":"Nucleotides acting at P2Y receptors: Connecting structure and function","volume":"88","author":"Jacobson","year":"2015","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/0953710021000062914","article-title":"Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets","volume":"14","author":"Jagroop","year":"2003","journal-title":"Platelets"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0435","article-title":"Exploration of alternative scaffolds for P2Y14 receptor antagonists containing a Biaryl Core","volume":"67","author":"Jung","year":"2020","journal-title":"Physiology & Behavior"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0440","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0026-895X(24)26501-9","article-title":"ATP, an agonist at the rat P2Y4 receptor, is an antagonist at the human P2Y4","volume":"57","author":"Kennedy","year":"2000","journal-title":"Molecular Pharmacology"},{"issue":"23","key":"10.1016\/j.pharmthera.2025.108796_bb0445","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1021\/jm030127+","article-title":"2-substitution of adenine nucleotide analogues containing a Bicyclo[3.1.0]hexane ring system locked in a northern conformation: Enhanced potency as P2Y1 receptor antagonists","volume":"46","author":"Kim","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0450","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2005.04.021","article-title":"Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor","volume":"70","author":"Kim","year":"2005","journal-title":"Biochemical Pharmacology"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108796_bb0455","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.bmcl.2017.09.043","article-title":"From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y2 receptor","volume":"27","author":"Kindon","year":"2017","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108796_bb0460","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.bjp.0704674","article-title":"2-Chloro-N6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine- 3\u2032,5\u2032-bisphosphate is a selective high affinity P2Y1 receptor antagonist: Commentary on Boyer et al","volume":"135","author":"King","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purinergic receptors in microglia: Functional modal shifts of microglia mediated by P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0470","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1074-7613(00)80364-7","article-title":"ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors","volume":"7","author":"Lammas","year":"1997","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0475","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1476-5381.1995.tb16382.x","article-title":"Pharmacological selectivity of the cloned human P2U-purinoceptor: Potent activation by diadenosine tetraphosphate","volume":"116","author":"Lazarowski","year":"1995","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-7-22","article-title":"Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines","volume":"7","author":"Lee","year":"2006","journal-title":"BMC Immunology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108796_bb0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01969000","article-title":"Histamine secretion from mast cells stimulated with bradykinin","volume":"30","author":"Lee","year":"1990","journal-title":"Agents and Actions"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0490","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.4049\/jimmunol.1301930","article-title":"Extracellular UDP and P2Y6 function as a danger signal to protect mice from vesicular stomatitis virus infection through an increase in IFN-\u03b2 production","volume":"193","author":"Li","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0495","first-page":"1","article-title":"Salvianolic acids from antithrombotic traditional Chinese medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors","volume":"8","author":"Liu","year":"2018","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0500","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.116.307401","article-title":"P2Y12 receptor modulates sepsis-induced inflammation","volume":"36","author":"Liverani","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0505","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1189\/jlb.1012518","article-title":"LPS-induced systemic inflammation is more severe in P2Y12 null mice","volume":"95","author":"Liverani","year":"2013","journal-title":"Journal of Leukocyte Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9112431","article-title":"Cell biology of viral infections","volume":"9","author":"Lozach","year":"2020","journal-title":"Cells"},{"issue":"April","key":"10.1016\/j.pharmthera.2025.108796_bb0515","first-page":"1","article-title":"Neuroinflammation in HIV-related neuropathic pain","volume":"12","author":"Lu","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0520","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1073\/pnas.90.11.5113","article-title":"Expression cloning of an ATP receptor from mouse neuroblastoma cells","volume":"90","author":"Lustig","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0525","first-page":"15","article-title":"Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors","volume":"1","author":"Mamedova","year":"2004","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21041391","article-title":"P2y12 inhibition beyond thrombosis: Effects on inflammation","volume":"21","author":"Mansour","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108796_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imbio.2010.03.010","article-title":"Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages","volume":"216","author":"Marques-da-Silva","year":"2011","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0540","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1462-5822.2011.01630.x","article-title":"Infection with Leishmania amazonensis upregulates purinergic receptor expression and induces host-cell susceptibility to UTP-mediated apoptosis","volume":"13","author":"Marques-da-Silva","year":"2011","journal-title":"Cellular Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bib848","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.64.1.104","article-title":"Pharmacological characterization of the human P2Y13 receptor","volume":"64","author":"Marteau","year":"2003","journal-title":"Molecular Pharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bb0545","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1021\/jm101591j","article-title":"Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate \u03b4-ester modifications as selective agonists of the P2Y4 receptor","volume":"54","author":"Maruoka","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0550","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/WCO.0000000000000807","article-title":"Chronic inflammation mediates brain injury in HIV infection: Relevance for cure strategies","volume":"33","author":"McArthur","year":"2020","journal-title":"Current Opinion in Neurology"},{"issue":"February","key":"10.1016\/j.pharmthera.2025.108796_bb0555","first-page":"797","article-title":"Survival to infection","volume":"323","author":"Mcmorran","year":"2009","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0560","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.109.157750","article-title":"NF546 [4,4\u2032-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4- methyl-phenylene)-carbonylimino))-bis(1,3-xylene-\u03b1,\u03b1\u2019- diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-de","volume":"332","author":"Meis","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108796_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0133502","article-title":"Pyrimidinergic receptor activation controls toxoplasma gondii infection in macrophages","volume":"10","author":"Moreira-Souza","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0570","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinph.2017.09.119","article-title":"The insular cortex and QTc interval in HIV+ and HIV\u2212 individuals: Is there an effect of sympathetic nervous system activity?","volume":"129","author":"Nagai","year":"2018","journal-title":"Clinical Neurophysiology"},{"issue":"5573","key":"10.1016\/j.pharmthera.2025.108796_bb0575","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"issue":"52","key":"10.1016\/j.pharmthera.2025.108796_bb0580","doi-asserted-by":"crossref","first-page":"30845","DOI":"10.1074\/jbc.270.52.30845","article-title":"Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene","volume":"270","author":"Nguyen","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0585","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0026-895X(25)09210-7","article-title":"Uridine nucleotide selectivity of three phospholipase C-activating P 2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor","volume":"50","author":"Nicholas","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0590","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2017.06.010","article-title":"Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases","volume":"180","author":"Nishimura","year":"2017","journal-title":"Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0595","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/dnares\/1.5.223","article-title":"Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1","volume":"1","author":"Nomura","year":"1994","journal-title":"DNA Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bb0600","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy","volume":"63","author":"O\u2019Brien","year":"2013","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1328897","article-title":"P2Y2-P2X7 receptors cross-talk in primed mesenteric endothelial cells upregulates NF-\u03baB signaling favoring mononuclear cell adhesion in schistosomiasis","volume":"14","author":"Oliveira","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0610","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vph.2016.02.005","article-title":"Increased expression of NTPDases 2 and 3 in mesenteric endothelial cells during schistosomiasis favors leukocyte adhesion through P2Y1 receptors","volume":"82","author":"Oliveira","year":"2016","journal-title":"Vascular Pharmacology"},{"issue":"34","key":"10.1016\/j.pharmthera.2025.108796_bb0615","doi-asserted-by":"crossref","first-page":"12795","DOI":"10.1074\/jbc.RA118.007236","article-title":"Streptococcus pneumoniae inhibits purinergic signaling and promotes purinergic receptor P2Y2 internalization in alveolar epithelial cells","volume":"294","author":"Olotu","year":"2019","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0620","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-894X(00)00612-0","article-title":"Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5\u2032-polyphosphates","volume":"11","author":"Pendergast","year":"2001","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"issue":"September","key":"10.1016\/j.pharmthera.2025.108796_bb0625","article-title":"Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation","volume":"206","author":"Pons","year":"2022","journal-title":"Biochemical Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108796_bb0630","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1021\/acs.jmedchem.7b00030","article-title":"Development of potent and selective antagonists for the UTP-activated P2Y 4 receptor","volume":"60","author":"Rafehi","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom12111564","article-title":"The defensive interactions of prominent infectious protozoan parasites: The host\u2019s complement system","volume":"12","author":"Rashidi","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bb0640","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1128\/IAI.02546-14","article-title":"Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular ATP release","volume":"82","author":"Ren","year":"2014","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0645","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signalling"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108796_bb0650","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/IAI.00074-10","article-title":"Extracellular ATP and P2Y receptor activation induce a pro-inflammatory host response in the human urinary tract","volume":"78","author":"S\u00e4ve","year":"2010","journal-title":"Infection and Immunity"},{"issue":"FEB","key":"10.1016\/j.pharmthera.2025.108796_bb0655","article-title":"The P2X7 receptor in inflammatory diseases: Angel or demon?","volume":"9","author":"Savio","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"37","key":"10.1016\/j.pharmthera.2025.108796_bb0660","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2174\/138161212803582504","article-title":"P2Y purinoceptors as potential emerging therapeutical target in vascular disease","volume":"18","author":"Schuchardt","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0665","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.20101805","article-title":"Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection","volume":"208","author":"S\u00e9ror","year":"2011","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0670","first-page":"435","article-title":"Ticagrelor reduces Thromboinflammatory markers in patients with pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC: Basic to Translational Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0675","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11302-005-5303-4","article-title":"Modulation of purinergic signaling by NPP-type ectophosphodiesterases","volume":"2","author":"Stefan","year":"2006","journal-title":"Purinergic Signalling"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108796_bb0680","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1074\/jbc.RA118.007188","article-title":"Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors","volume":"294","author":"Sueyoshi","year":"2019","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108796_bb0685","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.bjp.0703237","article-title":"The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties","volume":"129","author":"Sugidachi","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0690","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2016.06.023","article-title":"The active metabolite of prasugrel, R-138727, improves cerebral blood flow and reduces cerebral infarction and neurologic deficits in a non-human primate model of acute ischaemic stroke","volume":"788","author":"Sugidachi","year":"2016","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108796_bib844","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(24)12604-1","article-title":"Molecular cloning of the platelet P2TAC ADP receptor: Pharmacological comparison with another ADP receptor, the P2Y1 receptor","volume":"60","author":"Takasaki","year":"2001","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0695","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108796_bb0700","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-010-9456-y","article-title":"P2Y1 transient overexpression induced mineralization in spinal ligament cells derived from patients with ossification of the posterior longitudinal ligament of the cervical spine","volume":"88","author":"Tanaka","year":"2011","journal-title":"Calcified Tissue International"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108796_bb0705","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.ico.0000133993.14768.a9","article-title":"Double-masked, placebo-controlled safety and efficacy trial the treatment of dry eye","volume":"23","author":"Tauber","year":"2004","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108796_bb0710","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","article-title":"Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model","volume":"35","author":"Thomas","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"JUL","key":"10.1016\/j.pharmthera.2025.108796_bb0715","article-title":"Purinergic cooperation between P2Y2 and P2X7 receptors promote cutaneous Leishmaniasis control: Involvement of Pannexin-1 and leukotrienes","volume":"9","author":"Thorstenberg","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0720","article-title":"Purinergic cooperation between P2Y2 and P2X7 receptors promote cutaneous Leishmaniasis control: Involvement of Pannexin-1 and leukotrienes","volume":"9","author":"Thorstenberg","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0725","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/bbrc.1995.1798","article-title":"Cloning of rat and mouse P2Y Purinoceptors","volume":"211","author":"Tokuyama","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108796_bb0730","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1021\/jm050301p","article-title":"Synthesis and structure-activity relationships of suramin-derived P2Y 11 receptor antagonists with nanomolar potency","volume":"48","author":"Ullmann","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108796_bib841","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007168215748","article-title":"Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines","volume":"213","author":"Van Der Weyden","year":"2000","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108796_bb0735","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.4049\/jimmunol.0903908","article-title":"P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation","volume":"185","author":"Vanderstocken","year":"2010","journal-title":"The Journal of Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108796_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0050385","article-title":"Protective role of P2Y2 receptor against lung infection induced by pneumonia virus of mice","volume":"7","author":"Vanderstocken","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108796_bb0745","series-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\u2019 s public news and information","author":"Viecca","year":"2020"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11302-020-09689-z","article-title":"The role of purinergic P2Y12 and P2Y13 receptors in ADP\u03b2S-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats","volume":"16","author":"Villanueva-Castillo","year":"2020","journal-title":"Purinergic Signalling"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0755","doi-asserted-by":"crossref","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic signaling, DAMPs, and inflammation","volume":"318","author":"Virgilio","year":"2020","journal-title":"American Journal of Physiology - Cell Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0760","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/mol.62.5.1249","article-title":"Quantitation of the P2Y 1 receptor with a high affinity radiolabeled antagonist","volume":"62","author":"Waldo","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0765","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/mol.65.2.426","article-title":"Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor","volume":"65","author":"Waldo","year":"2004","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0770","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(93)81397-I","article-title":"Cloning and functional expression of a brain G-protein-coupled ATP receptor","volume":"324","author":"Webb","year":"1993","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0775","article-title":"P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications","volume":"187","author":"Woods","year":"2021","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0780","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/TP.0b013e318196305a","article-title":"Involvement of platelet activation by P2Y12 receptor in the development of transplant arteriosclerosis in mice","volume":"87","author":"Yashiro","year":"2009","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0785","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0790","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11302-017-9594-z","article-title":"P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2\u2032,3\u2032-dideoxycytidine","volume":"14","author":"Yi","year":"2018","journal-title":"Purinergic Signalling"},{"issue":"October 2023","key":"10.1016\/j.pharmthera.2025.108796_bb0795","article-title":"P2Y13 receptor involved in HIV-1 gp120 induced neuropathy in superior cervical ganglia through NLRP3 inflammasome activation","volume":"245","author":"Yin","year":"2024","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.pharmthera.2025.108796_bb0800","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1021\/jm300771j","article-title":"Identification of high-affinity P2Y12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone","volume":"55","author":"Zech","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108796_bb0805","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.110.002139","article-title":"Major contribution of the P2Y1 receptor in purinergic regulation of tnf\u03b1-induced vascular inflammation","volume":"123","author":"Zerr","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108796_bb0810","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jmcb\/mjy045","article-title":"IFN-stimulated P2Y13 protects mice from viral infection by suppressing the cAMP\/EPAC1 signaling pathway","volume":"11","author":"Zhang","year":"2018","journal-title":"Journal of Molecular Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0815","first-page":"100","article-title":"Two disparate ligand binding sites in the human P2Y1 receptor","volume":"176","author":"Zhang","year":"2015","journal-title":"Physiology & Behavior"},{"issue":"October 2023","key":"10.1016\/j.pharmthera.2025.108796_bb0820","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molimm.2024.02.005","article-title":"SARS-CoV-2 spike protein receptor binding domain promotes IL-6 and IL-8 release via ATP\/P2Y2 and ERK1\/2 signaling pathways in human bronchial epithelia","volume":"167","author":"Zhang","year":"2024","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0825","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cmi.2016.56","article-title":"Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling","volume":"15","author":"Zhang","year":"2018","journal-title":"Cellular and Molecular Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108796_bb0830","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.4049\/jimmunol.1002946","article-title":"P2Y6 agonist uridine 5\u2032-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant Protein-1\u2013mediated monocytes\/macrophages recruitment","volume":"186","author":"Zhang","year":"2011","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108796_bb0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1466-8","article-title":"HIV-1 tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K\/Akt and ERK MAPK pathways","volume":"16","author":"Zhou","year":"2019","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108796_bb0840","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/cmi.2008.19","article-title":"CAMP modulates macrophage development by suppressing M-CSF-induced MAPKs activation","volume":"5","author":"Zhu","year":"2008","journal-title":"Cellular and Molecular Immunology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:27:33Z","timestamp":1740691653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":176,"alternative-id":["S0163725825000087"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108796","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G protein-coupled purinergic P2Y receptors in infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108796"}}